Genitourinary Cancer

Top Story

Dose-dense chemotherapy improves bladder cancer outcomes following cystectomy

Dose-dense chemotherapy improves bladder cancer outcomes following cystectomy
September 18, 2018
In the Journals Plus

Supportive therapy alleviates depression associated with advanced cancer

September 14, 2018
Patients with advanced cancer experienced alleviated depressive
In the Journals Plus

Fatal toxic events possible, but rare, with immune checkpoint inhibitors

September 13, 2018
Fatal toxic events occurred in about 0.3% to 1.3% of patients treated with immune checkpoint inhibitors, according to a meta-analysis of adverse outcomes reports and…

Avelumab plus axitinib improves PFS in advanced renal cell carcinoma

September 11, 2018
Treatment with avelumab and axitinib improved PFS among patients with advanced renal cell carcinoma compared with sunitinib monotherapy, according to interim analysis…
More Headlines »
CME ABIM MOC

Ace the Case: A 54-Year-Old Man With Intermittent, Painless Hematuria for the Past 4 Weeks

There is no commercial support for this activity.

This “Ace the Case” study will discuss the treatment of a 54-year-old man who presents with intermittent…
More »
Video
Meeting News

VIDEO: Lenvatinib-pembrolizumab shows promise in several cancer types

June 22, 2018
More »
Resource Centers
Immuno-Oncology Resource Center

Immuno-Oncology Resource Center

CME CNE CPE

Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

The integration of immune checkpoint inhibitors into treatment algorithms for the management of advanced genitourinary…
More »